US Broker Ratings

Becton, Dickinson and Company (BDX) Stock Analysis: Assessing Growth Potential with a 5.39% Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and diverse product offerings in the medical instruments..

HealthEquity, Inc. (HQY) Investor Outlook: Exploring a Potential 46% Upside with Strong Buy Ratings

HealthEquity, Inc. (NASDAQ: HQY), a leader in technology-enabled health savings solutions, is drawing significant investor interest thanks to its robust growth potential and compelling valuation metrics. With an average analyst..

ResMed Inc. (RMD) Stock Analysis: A Healthcare Leader with 14.8% Potential Upside

ResMed Inc. (NYSE: RMD) is a prominent player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $37.82 billion, ResMed is a formidable force..

Novo Nordisk A/S (NVO) Stock Analysis: A 13.84% Upside Potential Amid Healthcare Sector Challenges

Novo Nordisk A/S (NYSE: NVO), a heavyweight in the healthcare sector with a market cap of $210.86 billion, has long been a key player in the pharmaceutical industry. Specializing in..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Unveiling a 32% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST) is a key player in the healthcare sector, specifically within the medical instruments and supplies industry. With its headquarters in Exton, Pennsylvania, the company..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Unpacking a 103.76% Potential Upside in the Biotech Space

Summit Therapeutics Inc. (NASDAQ: SMMT) is an intriguing player in the healthcare sector, specifically within the biotechnology industry. Headquartered in Miami, Florida, and boasting a market capitalization of $11.87 billion,..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 56% Potential Upside in the Health Information Sector

Doximity, Inc. (DOCS), a prominent player in the healthcare technology sector, offers a compelling investment proposition with a potential upside of 56.37% based on its average target price. Operating as..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 21% Potential Upside

Intuitive Surgical, Inc. (ISRG), a titan within the healthcare sector, continues to capture investor interest with its cutting-edge medical instruments and robust market presence. With a substantial market cap of..

Genmab A/S (GMAB) Stock Analysis: A Biotech Powerhouse with 29.55% Potential Upside

For investors with an eye on the healthcare sector, Genmab A/S (NASDAQ: GMAB) presents a compelling opportunity within the biotechnology industry. Headquartered in Copenhagen, Denmark, Genmab has established itself as..

Medtronic plc (MDT) Stock Analysis: Exploring a 15.39% Upside Potential in the Healthcare Sector

Medtronic plc (MDT), a behemoth in the healthcare sector with a market capitalization of $124.23 billion, stands as a pivotal player in the medical devices industry. Headquartered in Galway, Ireland,..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring Growth Potential in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a major player in the global medical devices market, is drawing attention from investors with its promising growth prospects and stable financial performance...

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a -0.37% Potential Downside Amidst Global Expansion

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, operates as a leading pharmaceutical company with a robust presence in North America, Europe, India, and beyond...

ICON plc (ICLR) Stock Analysis: Exploring the 58% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a prominent player in the healthcare sector, stands as a beacon of interest for investors looking to capitalize on the healthcare industry’s dynamic landscape. With a..

Regeneron Pharmaceuticals (REGN) Stock Analysis: Navigating Growth with a Promising 11.58% Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a prominent player in the biotechnology sector, consistently pioneering advancements in healthcare through the discovery and commercialization of innovative medicines. As of its..

Biogen Inc. (BIIB) Stock Analysis: Gauging the 6.67% Potential Upside Amidst a Challenging Revenue Landscape

Biogen Inc. (BIIB), a titan in the healthcare sector, is a prominent player in the drug manufacturing industry, with a market capitalization of $28.18 billion. Despite facing some challenges, particularly..

Zoetis Inc. (ZTS) Stock Analysis: Unveiling a 17.25% Potential Upside in the Animal Health Giant

Zoetis Inc. (NYSE: ZTS), a prominent player in the healthcare sector specializing in the animal health industry, continues to capture investor interest with its robust market presence and promising growth..

Haleon plc (HLN) Stock Analysis: A Look at Growth Potential and Analyst Ratings

Haleon plc, trading under the ticker HLN, represents a prominent player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in Weybridge, United Kingdom, Haleon..

The Cooper Companies, Inc. (COO) Stock Analysis: Healthcare Giant with an 8.24% Upside Potential

The Cooper Companies, Inc. (NYSE: COO), a stalwart in the healthcare sector, operates within the medical instruments and supplies industry, primarily focusing on contact lenses and women’s health. With a..

AstraZeneca PLC (AZN) Stock Analysis: Navigating a -19.37% Potential Downside Amidst Robust Dividend Yield

AstraZeneca PLC (NASDAQ: AZN), a formidable player in the healthcare sector, commands a notable market capitalization of $316.57 billion. This UK-based biopharmaceutical giant is renowned for its innovative approach to..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a Promising 11.79% Upside in the Healthcare Sector

Tenet Healthcare Corporation (NYSE: THC) is making waves in the healthcare sector, capturing the attention of investors with its robust growth metrics and a compelling potential upside of 11.79%. As..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds